Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CCKBR | P32239 | 3/20 | 0.55 |
| ▸ | MMP2 | P08253 | 6/20 | 0.53 |
| ▸ | MMP9 | P14780 | 6/20 | 0.53 |
| ▸ | MMP8 | P22894 | 6/20 | 0.53 |
| ▸ | MMP14 | P50281 | 6/20 | 0.53 |
| ▸ | GHSR | Q92847 | 4/20 | 0.52 |
| ▸ | MMP11 | P24347 | 1/20 | 0.52 |
| ▸ | KISS1R | Q969F8 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22339065 | 0.93 | CCKBR (0.63) | CCKBRMMP2MMP9MMP8MMP14 | |
| SCHEMBL14811912 | 0.90 | MC4R (0.57) | CCKBRKISS1R | |
| SCHEMBL22330610 | 0.87 | GRPR (0.54) | CCKBRMMP2MMP9MMP8MMP14 | |
| SCHEMBL30294163 | 0.87 | GRPR (0.54) | CCKBRMMP2MMP9MMP8MMP14 | |
| SCHEMBL20045524 | 0.87 | GRPR (0.54) | CCKBRMMP2MMP9MMP8MMP14 | |
| SCHEMBL22339063 | 0.86 | MC4R (0.53) | CCKBRKISS1R | |
| SCHEMBL22339064 | 0.85 | MC4R (0.55) | CCKBRKISS1R | |
| SCHEMBL29489105 | 0.84 | KISS1R (0.56) | CCKBRGHSRKISS1R | |
| SCHEMBL5501891 | 0.84 | KISS1R (0.55) | KISS1R | |
| SCHEMBL22485392 | 0.83 | MC4R (0.54) | CCKBRKISS1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3704134-B1 | ANTIMICROBIAL TETRAPEPTIDES | DSM IP ASSETS BV (NL) | 2021-12-22 | — | — | EP | disclosed |
| US-20200308222-A1 | ANTIMICROBIAL TETRAPEPTIDES | DSM IP ASSETS B.V. (NL) | 2020-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200308222-A1 | ANTIMICROBIAL TETRAPEPTIDES | VIP, CLPP, SGTA | CCKBR 2568/4885MMP2 2589/4885MMP9 3323/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.